$750 Million is the total value of Logos Global Management LP's 56 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 72.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMVT | Sell | IMMUNOVANT INC | $61,424,000 | +43.9% | 1,600,000 | -28.9% | 8.20% | +41.2% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $60,705,000 | +47.6% | 2,250,000 | +28.6% | 8.10% | +44.8% |
| OLMA | OLEMA PHARMACEUTICALS INC | $46,236,856 | +36.8% | 3,743,875 | 0.0% | 6.17% | +34.2% | |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $40,467,750 | +714.7% | 1,975,000 | +690.0% | 5.40% | +698.7% |
| CYTK | Sell | CYTOKINETICS INC | $36,825,000 | -31.6% | 1,250,000 | -24.2% | 4.91% | -32.9% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $30,348,000 | +25.0% | 600,000 | +15.4% | 4.05% | +22.6% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $28,530,000 | -49.9% | 750,000 | +20.0% | 3.81% | -50.9% |
| Buy | STRUCTURE THERAPEUTICS INCsponsored ads | $25,210,000 | +51.6% | 500,000 | +25.0% | 3.36% | +48.7% | |
| APLS | New | APELLIS PHARMACEUTICALS INCcall | $24,726,000 | – | 650,000 | +100.0% | 3.30% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $24,244,000 | -29.4% | 200,000 | -33.3% | 3.24% | -30.8% |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $23,355,000 | -22.1% | 450,000 | -10.0% | 3.12% | -23.6% |
| Buy | ICOSAVAX INC | $21,434,493 | -0.3% | 2,765,741 | +27.7% | 2.86% | -2.2% | |
| DYN | Buy | DYNE THERAPEUTICS INC | $19,532,800 | -2.5% | 2,180,000 | +22.5% | 2.61% | -4.3% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $19,445,350 | +156.2% | 115,000 | +228.6% | 2.59% | +151.4% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $16,875,000 | -40.3% | 150,000 | -50.0% | 2.25% | -41.5% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $16,107,000 | -39.8% | 1,050,000 | -6.7% | 2.15% | -41.0% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $15,372,000 | +45.2% | 450,000 | +63.6% | 2.05% | +42.4% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $15,281,000 | – | 700,000 | +100.0% | 2.04% | – |
| New | ROIVANT SCIENCES LTD | $14,016,000 | – | 1,200,000 | +100.0% | 1.87% | – | |
| BBIO | Sell | BRIDGEBIO PHARMA INCcall | $13,185,000 | +17.9% | 500,000 | -23.1% | 1.76% | +15.6% |
| MRTX | New | MIRATI THERAPEUTICS INC | $13,068,000 | – | 300,000 | +100.0% | 1.74% | – |
| ANNX | Buy | ANNEXON INC | $12,508,000 | +1.5% | 5,300,000 | +51.4% | 1.67% | -0.4% |
| IMTX | Buy | IMMATICS N.V | $12,159,000 | +110.7% | 1,050,000 | +110.0% | 1.62% | +106.6% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $11,876,702 | -32.6% | 5,032,501 | +79.9% | 1.58% | -33.9% |
| ALLK | Sell | ALLAKOS INC | $10,555,500 | -53.9% | 4,650,000 | -11.4% | 1.41% | -54.8% |
| BBIO | Buy | BRIDGEBIO PHARMA INC | $10,548,000 | +104.4% | 400,000 | +33.3% | 1.41% | +100.4% |
| RYTM | New | RHYTHM PHARMACEUTICALS INC | $9,170,000 | – | 400,000 | +100.0% | 1.22% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $8,667,000 | – | 900,000 | +100.0% | 1.16% | – |
| Sell | VENTYX BIOSCIENCES INC | $7,814,250 | -4.7% | 225,000 | -10.0% | 1.04% | -6.5% | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $7,435,000 | – | 250,000 | +100.0% | 0.99% | – |
| GRCL | Buy | GRACELL BIOTECHNOLOGIES INCsponsored ads | $7,272,000 | +6.0% | 2,525,000 | +40.3% | 0.97% | +4.0% |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $7,030,000 | – | 950,000 | +100.0% | 0.94% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $6,920,000 | – | 250,000 | +100.0% | 0.92% | – |
| MOR | Sell | MORPHOSYS AGsponsored ads | $6,384,000 | -28.8% | 950,000 | -20.8% | 0.85% | -30.1% |
| RPTX | New | REPARE THERAPEUTICS INCcall | $6,040,000 | – | 500,000 | +100.0% | 0.81% | – |
| GERN | Buy | GERON CORP | $5,830,000 | -17.4% | 2,750,000 | +25.0% | 0.78% | -19.0% |
| MRUS | New | MERUS N V | $5,777,100 | – | 245,000 | +100.0% | 0.77% | – |
| ALXO | ALX ONCOLOGY HLDGS INC | $4,800,000 | -36.1% | 1,000,000 | 0.0% | 0.64% | -37.3% | |
| ETNB | New | 89BIO INC | $4,786,400 | – | 310,000 | +100.0% | 0.64% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $4,550,000 | – | 1,000,000 | +100.0% | 0.61% | – |
| DCTH | Sell | DELCATH SYS INC | $4,229,998 | -38.4% | 1,044,444 | -11.4% | 0.56% | -39.7% |
| ENLIVEN THERAPEUTICS INC | $4,194,658 | -33.1% | 307,076 | 0.0% | 0.56% | -34.3% | ||
| ASTRIA THERAPEUTICS INC | $4,065,402 | -10.4% | 544,960 | 0.0% | 0.54% | -12.2% | ||
| New | SOLENO THERAPEUTICS INC | $3,688,750 | – | 125,000 | +100.0% | 0.49% | – | |
| RPTX | New | REPARE THERAPEUTICS INC | $3,624,000 | – | 300,000 | +100.0% | 0.48% | – |
| VERV | New | VERVE THERAPEUTICS INC | $2,850,900 | – | 215,000 | +100.0% | 0.38% | – |
| New | ZURA BIO LTD | $2,798,400 | – | 424,000 | +100.0% | 0.37% | – | |
| New | AEGLEA BIOTHERAPEUTICS INC | $2,572,500 | – | 210,000 | +100.0% | 0.34% | – | |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $1,322,500 | – | 115,000 | +100.0% | 0.18% | – |
| VIGIL NEUROSCIENCE INC | $1,015,422 | -42.7% | 188,390 | 0.0% | 0.14% | -44.0% | ||
| New | IO BIOTECH INC | $696,296 | – | 493,827 | +100.0% | 0.09% | – | |
| IMUX | IMMUNIC INC | $619,140 | -41.4% | 421,184 | 0.0% | 0.08% | -42.4% | |
| New | LEAP THERAPEUTICS INC | $488,887 | – | 354,266 | +100.0% | 0.06% | – | |
| TYRA BIOSCIENCES INC | $438,877 | -19.1% | 31,872 | 0.0% | 0.06% | -20.3% | ||
| LIANBIOsponsored ads | $417,200 | -34.6% | 280,000 | 0.0% | 0.06% | -35.6% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $6,667 | -39.5% | 66,666 | 0.0% | 0.00% | 0.0% | |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -3,142,880 | -100.0% | -0.19% | – |
| DBVT | Exit | DBV TECHNOLOGIES S Asponsored adr | $0 | – | -1,200,000 | -100.0% | -0.31% | – |
| Exit | TENAYA THERAPEUTICS INC | $0 | – | -600,000 | -100.0% | -0.48% | – | |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -200,000 | -100.0% | -0.67% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -500,000 | -100.0% | -0.72% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -525,000 | -100.0% | -0.74% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -525,000 | -100.0% | -0.78% | – | |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -650,000 | -100.0% | -1.06% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -100,000 | -100.0% | -1.18% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -2,800,000 | -100.0% | -1.25% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -800,000 | -100.0% | -1.29% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -250,000 | -100.0% | -1.38% | – |
| BCYC | Exit | BICYCLE THERAPEUTICS PLCsponsored ads | $0 | – | -520,000 | -100.0% | -1.80% | – |
| RCUS | Exit | ARCUS BIOSCIENCES INC | $0 | – | -750,000 | -100.0% | -2.07% | – |
| Exit | ARCELLX INC | $0 | – | -500,000 | -100.0% | -2.15% | – | |
| BIIB | Exit | BIOGEN INC | $0 | – | -100,000 | -100.0% | -3.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.